Global HIV control funding falls short of need. To maximize health outcomes, it is critical that national governments sustain reasonable commitments, and that international donor assistance be distributed according to country needs and funding gaps. We develop a country classification framework in t...erms of actual versus expected national domestic funding, considering resource needs and donor financing. With UNAIDS and World Bank data, we examine domestic and donor HIV program funding in relation to need in 84 low- and middle-income countries. We estimate expected domestic contributions per person living with HIV (PLWH) as a function of per capita income, relative size of the health sector, and per capita foreign debt service.
more
International Journal of Infectious Diseases 32 (2015) 111–117
The Lancet Global Health January 24, 2022
PLoS ONE 9(6): e99880. doi:10.1371/journal.pone.0099880
Published June 17, 2014
Public Health Action
vol 5 no 3 published 21 september 2015
Ensuring Access to Simple, Safe and Effective First-Line Medicines for Tuberculosis.
Accessed in November 2017.
Eur Respir J 2017; 50: 1700918
Systematic screening for active tuberculosis: an operational guide.
Update 2021; Immunization, Vaccines and Biologicals
Research
BMJ 2014;349:g4643 doi: 10.1136/bmj.g4643 (Published 5 August 2014), 1-11